Cargando…

Plasmid Profiling and Occurrence of β-Lactamase Enzymes in Multidrug-Resistant Uropathogenic Escherichia coli in Kathmandu, Nepal

INTRODUCTION: Extended-spectrum β-lactamases (ESBL) among Gram-negative bacteria, predominantly Escherichia coli (E. coli), in Nepal, have been rising. The main objectives of this study were to determine the prevalence of uropathogenic E. coli, antibiotic resistance, ESBLs, ABLs (AmpC type β-lactama...

Descripción completa

Detalles Bibliográficos
Autores principales: Thapa Shrestha, Upendra, Shrestha, Sabnum, Adhikari, Nabaraj, Rijal, Komal Raj, Shrestha, Basudha, Adhikari, Bipin, Banjara, Megha Raj, Ghimire, Prakash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320882/
https://www.ncbi.nlm.nih.gov/pubmed/32606839
http://dx.doi.org/10.2147/IDR.S250591
_version_ 1783551337161555968
author Thapa Shrestha, Upendra
Shrestha, Sabnum
Adhikari, Nabaraj
Rijal, Komal Raj
Shrestha, Basudha
Adhikari, Bipin
Banjara, Megha Raj
Ghimire, Prakash
author_facet Thapa Shrestha, Upendra
Shrestha, Sabnum
Adhikari, Nabaraj
Rijal, Komal Raj
Shrestha, Basudha
Adhikari, Bipin
Banjara, Megha Raj
Ghimire, Prakash
author_sort Thapa Shrestha, Upendra
collection PubMed
description INTRODUCTION: Extended-spectrum β-lactamases (ESBL) among Gram-negative bacteria, predominantly Escherichia coli (E. coli), in Nepal, have been rising. The main objectives of this study were to determine the prevalence of uropathogenic E. coli, antibiotic resistance, ESBLs, ABLs (AmpC type β-lactamases), MBLs (metallo-β-lactamases) and KPCs (Klebsiella pneumoniae carbapenemases) and their correlation with plasmid profiling patterns among patients with urinary tract infections in a tertiary hospital in Kathmandu, Nepal. METHODS: The mid-stream urine samples collected from patients were inoculated in cystine–lactose–electrolyte-deficient (CLED) agar plates. E. coli producing ESBLs, ABLs, MBLs/KPC were identified phenotypically using standard microbiological methods. Plasmids were extracted by alkaline lysis method from E. coli isolates and profiled using agarose gel electrophoresis. RESULTS: Out of the total 2661 urine samples, E. coli were isolated in 64.34% (507/788), among which 170 (33.53%) were multidrug-resistant (MDR) isolates. All MDR isolates were resistant to amoxicillin and third-generation cephalosporins but were highly sensitive to imipenem (94.12%, 160/170), amikacin (92.94%, 158/170) and nitrofurantoin (86.47%, 147/170). Among 170 MDR isolates, 78.2% (133/170) were ESBLs, 46.3% (50/170) were AmpC, 11.2% (19/170) were MBL and 0.6% (1/170) were KPC producers. Coproduction of β-lactamases was detected in 24.12% (41/170) of isolates. E. coli isolates showed one plasmid (>33.5 kb), which was present in all the isolates. Overall, 44 different plasmid profile groups were identified based on molecular weight and number of plasmids. β-Lactamase producers were relatively resistant to the higher number of antibiotics tested (≤10) than non-producers (≤8), and the number of plasmids were higher in β-lactamase producers (≤7) than those in non-producers (≤5). CONCLUSION: The higher prevalence of the ESBLs, AmpCs, KPCs and MBLs along with their coproduction in E. coli isolates highlights the importance of routine surveillance of ESBLs, AmpCs, KPCs and MBLs in microbiology laboratories using various phenotypic methods.
format Online
Article
Text
id pubmed-7320882
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-73208822020-06-29 Plasmid Profiling and Occurrence of β-Lactamase Enzymes in Multidrug-Resistant Uropathogenic Escherichia coli in Kathmandu, Nepal Thapa Shrestha, Upendra Shrestha, Sabnum Adhikari, Nabaraj Rijal, Komal Raj Shrestha, Basudha Adhikari, Bipin Banjara, Megha Raj Ghimire, Prakash Infect Drug Resist Original Research INTRODUCTION: Extended-spectrum β-lactamases (ESBL) among Gram-negative bacteria, predominantly Escherichia coli (E. coli), in Nepal, have been rising. The main objectives of this study were to determine the prevalence of uropathogenic E. coli, antibiotic resistance, ESBLs, ABLs (AmpC type β-lactamases), MBLs (metallo-β-lactamases) and KPCs (Klebsiella pneumoniae carbapenemases) and their correlation with plasmid profiling patterns among patients with urinary tract infections in a tertiary hospital in Kathmandu, Nepal. METHODS: The mid-stream urine samples collected from patients were inoculated in cystine–lactose–electrolyte-deficient (CLED) agar plates. E. coli producing ESBLs, ABLs, MBLs/KPC were identified phenotypically using standard microbiological methods. Plasmids were extracted by alkaline lysis method from E. coli isolates and profiled using agarose gel electrophoresis. RESULTS: Out of the total 2661 urine samples, E. coli were isolated in 64.34% (507/788), among which 170 (33.53%) were multidrug-resistant (MDR) isolates. All MDR isolates were resistant to amoxicillin and third-generation cephalosporins but were highly sensitive to imipenem (94.12%, 160/170), amikacin (92.94%, 158/170) and nitrofurantoin (86.47%, 147/170). Among 170 MDR isolates, 78.2% (133/170) were ESBLs, 46.3% (50/170) were AmpC, 11.2% (19/170) were MBL and 0.6% (1/170) were KPC producers. Coproduction of β-lactamases was detected in 24.12% (41/170) of isolates. E. coli isolates showed one plasmid (>33.5 kb), which was present in all the isolates. Overall, 44 different plasmid profile groups were identified based on molecular weight and number of plasmids. β-Lactamase producers were relatively resistant to the higher number of antibiotics tested (≤10) than non-producers (≤8), and the number of plasmids were higher in β-lactamase producers (≤7) than those in non-producers (≤5). CONCLUSION: The higher prevalence of the ESBLs, AmpCs, KPCs and MBLs along with their coproduction in E. coli isolates highlights the importance of routine surveillance of ESBLs, AmpCs, KPCs and MBLs in microbiology laboratories using various phenotypic methods. Dove 2020-06-23 /pmc/articles/PMC7320882/ /pubmed/32606839 http://dx.doi.org/10.2147/IDR.S250591 Text en © 2020 Thapa Shrestha et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Thapa Shrestha, Upendra
Shrestha, Sabnum
Adhikari, Nabaraj
Rijal, Komal Raj
Shrestha, Basudha
Adhikari, Bipin
Banjara, Megha Raj
Ghimire, Prakash
Plasmid Profiling and Occurrence of β-Lactamase Enzymes in Multidrug-Resistant Uropathogenic Escherichia coli in Kathmandu, Nepal
title Plasmid Profiling and Occurrence of β-Lactamase Enzymes in Multidrug-Resistant Uropathogenic Escherichia coli in Kathmandu, Nepal
title_full Plasmid Profiling and Occurrence of β-Lactamase Enzymes in Multidrug-Resistant Uropathogenic Escherichia coli in Kathmandu, Nepal
title_fullStr Plasmid Profiling and Occurrence of β-Lactamase Enzymes in Multidrug-Resistant Uropathogenic Escherichia coli in Kathmandu, Nepal
title_full_unstemmed Plasmid Profiling and Occurrence of β-Lactamase Enzymes in Multidrug-Resistant Uropathogenic Escherichia coli in Kathmandu, Nepal
title_short Plasmid Profiling and Occurrence of β-Lactamase Enzymes in Multidrug-Resistant Uropathogenic Escherichia coli in Kathmandu, Nepal
title_sort plasmid profiling and occurrence of β-lactamase enzymes in multidrug-resistant uropathogenic escherichia coli in kathmandu, nepal
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320882/
https://www.ncbi.nlm.nih.gov/pubmed/32606839
http://dx.doi.org/10.2147/IDR.S250591
work_keys_str_mv AT thapashresthaupendra plasmidprofilingandoccurrenceofblactamaseenzymesinmultidrugresistanturopathogenicescherichiacoliinkathmandunepal
AT shresthasabnum plasmidprofilingandoccurrenceofblactamaseenzymesinmultidrugresistanturopathogenicescherichiacoliinkathmandunepal
AT adhikarinabaraj plasmidprofilingandoccurrenceofblactamaseenzymesinmultidrugresistanturopathogenicescherichiacoliinkathmandunepal
AT rijalkomalraj plasmidprofilingandoccurrenceofblactamaseenzymesinmultidrugresistanturopathogenicescherichiacoliinkathmandunepal
AT shresthabasudha plasmidprofilingandoccurrenceofblactamaseenzymesinmultidrugresistanturopathogenicescherichiacoliinkathmandunepal
AT adhikaribipin plasmidprofilingandoccurrenceofblactamaseenzymesinmultidrugresistanturopathogenicescherichiacoliinkathmandunepal
AT banjaramegharaj plasmidprofilingandoccurrenceofblactamaseenzymesinmultidrugresistanturopathogenicescherichiacoliinkathmandunepal
AT ghimireprakash plasmidprofilingandoccurrenceofblactamaseenzymesinmultidrugresistanturopathogenicescherichiacoliinkathmandunepal